Japan startup event and reception at MBC Biolabs

Event Information

Share this event

Date and Time

Location

Location

MBC Biolabs

953 Indiana St

San Francisco, CA 94107

View Map

Event description

Description

Beyond Next Ventures and MBC Biolabs invite you to explore the latest in Japanese life science innovation on January 10th, when seven startups specially selected for the Tokyo prefectural government's Blockbuster TOKYO initiative will pitch at MBC Biolabs. The pitches will be followed by a networking reception, and the event will provide a unique opportunity to learn about and access Japan's burgeoning bioventure ecosystem.


Date/time: January 10th from 2:30-4:30 pm, with networking reception following

Location: MBC Biolabs at 953 Indiana St, San Francisco, CA 94107


Companies:


TokioTHERA - Novel cancer immunotherapy with both onset prevention and curative effects.


RESVO - Mental heath diagnostic technology. http://resvo-inc.com/


Restore vision- Gene therapy for visual regeneration.


BRAIZON Therapeutics Co., Ltd. - Brain-targeted drug-delivery systems enabling new CNS therapies. http://www.braizon.com/en/index.html

Myoridge - Induced pluripotent stem cell-derived cardiomyocytes for regenerative medicine and drug screening.

https://myoridge.co.jp/en/


AIBIOS - Optimization of drug discovery for rare/orphan diseases focusing on immunology, neurodegeneration, and ophthalmology. https://www.aibios.co.jp/


Metcela- Revolutionary cell therapy for heart failure using VCAM-1-positive cardiac fibroblasts. https://www.metcela.com/en/#pll_switcher


Thinkcyte - AI-driven "ghost cytometry" cell sorting that does not require biomarkers (raised ~US $3 million so far, selected for Fall 2018 batch of Berkeley SkyDeck).


About the hosts:


MBC BioLabs provides space as small as a single bench in a fully equipped, premier shared laboratory environment. Scientist-entrepreneurs can conduct experiments immediately and at greatly reduced cost, accelerating the development and deployment of novel biotechnologies. Since the 953 Indiana St. facility opened in 2013, MBC BioLabs companies have raised over $2.4 billion dollars to deliver groundbreaking therapies, discovery tools, and services to markets hungry for innovation. For more information about MBC BioLabs, visit http://mbcbiolabs.com/.


Beyond Next Ventures is a seed/early-stage Tokyo-based venture capital firm focusing on medtech and life science. Their first fund was established in 2015, with US $55 million committed as the lead investor in 23 companies. Their second fund of US $100 million was established in October 2018. They also serve as a certified venture capital firm for Japanese government-associated organizations such as the New Energy and Industrial Technology Development Organization and the Program for Start-ups from Advanced Research & Technology. They also operate BRAVE, Japan's largest university startup accelerator, and have been exclusively tasked by the Tokyo Prefectural Government with operating the Blockbuster TOKYO accelerator for drug discovery startups. Finally, their Innovation Leaders Program gives employees of large corporations the opportunity to extern/embed at startups, and in Feburary 2018 they established a wet lab laboratory space in Tokyo to support and advance the local biotech ecosystem. For more information about Beyond Next Ventures, visit http://beyondnextventures.com/.


Date and Time

Location

MBC Biolabs

953 Indiana St

San Francisco, CA 94107

View Map

Save This Event

Event Saved